$OGN

Law firm probes four companies over potential M&A fairness violations and fiduciary duty breaches regarding shareholder consideration.

Halper Sadeh investigates four major acquisitions for potential undervaluation and fiduciary breaches, seeking higher prices for shareholders.

Sirius XM explores iHeartMedia acquisition while Uber buys FlyTaxi and Sun Pharma completes $11.75B Organon deal. Multiple bankruptcies filed.

Halper Sadeh LLC investigates $OGN, $XOMA, $RMAX, $SLNO acquisitions for potential shareholder harm and fiduciary breaches.

Sun Pharma agrees to acquire Organon for $14/share in all-cash deal, sending shares up 16.87% as women's health firm finds exit after struggling 2021 Merck spinoff.

Dow futures fall on Trump's Iran talks cancellation while S&P 500 gains. Organon surges 15% on $11.75B acquisition; Fed meets Wednesday with rates unchanged expected.

Sun Pharma finalizes $12B binding offer for Organon, marking India's largest overseas pharma acquisition amid industry consolidation.

Sio Capital Management invested $24.53 million in Organon ($OGN) at $6.03/share, betting on turnaround potential despite 61% annual decline. Company maintains flat 2026 guidance with $1.9B adjusted EBITDA.

Organon discontinues second Forendo drug candidate for PCOS, eliminating all programs from 2021 acquisition. KDventures writes off remaining contingent consideration entirely.

Organon discontinues PCOS drug candidate, marking total failure of KDventures' 2021 Forendo acquisition. Contingent consideration fully written off after second portfolio termination.